This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cuenca-Estrella, M.
Right arrow Articles by Rodriguez-Tudela, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cuenca-Estrella, M.
Right arrow Articles by Rodriguez-Tudela, J. L.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 2009, p. 2192-2195, Vol. 53, No. 5
0066-4804/09/$08.00+0     doi:10.1128/AAC.01543-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Activity Profile In Vitro of Micafungin against Spanish Clinical Isolates of Common and Emerging Species of Yeasts and Molds{triangledown}

Manuel Cuenca-Estrella,* Alicia Gomez-Lopez, Emilia Mellado, Araceli Monzon, Maria J. Buitrago, and Juan L. Rodriguez-Tudela

Mycology Department, Spanish National Center for Microbiology, Instituto de Salud Carlos III, Madrid, Spain

Received 19 November 2008/ Returned for modification 24 January 2009/ Accepted 4 February 2009

A collection of 2,278 isolates belonging to 86 different fungal species was tested with micafungin and eight other drugs using the EUCAST procedures. Micafungin was active against species of Candida and Aspergillus (even azole-resistant species) as well as Penicillium spp., Scedosporium apiospermum, and Acremonium spp. It was inactive for species of Basidiomycota and Mucorales and for multiresistant species such as those of Fusarium.


* Corresponding author. Mailing address: Servicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Ctra. Majadahonda-Pozuelo Km 2, 28220 Majadahonda, Madrid, Spain. Phone: 34-91-8223661. Fax: 34-91-5097966. E-mail: mcuenca-estrella{at}isciii.es

{triangledown} Published ahead of print on 17 February 2009.


Antimicrobial Agents and Chemotherapy, May 2009, p. 2192-2195, Vol. 53, No. 5
0066-4804/09/$08.00+0     doi:10.1128/AAC.01543-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Alcazar-Fuoli, L., Mellado, E., Alastruey-Izquierdo, A., Cuenca-Estrella, M., Rodriguez-Tudela, J. L. (2009). Species Identification and Antifungal Susceptibility Patterns of Species Belonging to Aspergillus Section Nigri. Antimicrob. Agents Chemother. 53: 4514-4517 [Abstract] [Full Text]